Expression of dopamine 2 receptor subtype mRNA in clinically nonfunctioning pituitary adenomas.

about

Optimal management of non-functioning pituitary adenomas.Dopamine receptor subtype 2 expression profile in nonfunctioning pituitary adenomas and in vivo response to cabergoline therapy.Dopamine Agonists for Pituitary Adenomas

P2860

Q38547977-95CDCC0E-8770-4CB6-8990-E1EFBE08D463 Q48449241-E976C8AA-B394-4FE3-8A46-D95FBD08119D Q58729410-3AFCEC93-ABBC-410B-9199-F0650BE8DE37

P2860

Expression of dopamine 2 receptor subtype mRNA in clinically nonfunctioning pituitary adenomas.

Item

http://www.wikidata.org/entity/Q54360050

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Expression of dopamine 2 recep ...... unctioning pituitary adenomas.

@en

Expression of dopamine 2 recep ...... unctioning pituitary adenomas.

@nl

type

Item

label

Expression of dopamine 2 recep ...... unctioning pituitary adenomas.

@en

Expression of dopamine 2 recep ...... unctioning pituitary adenomas.

@nl

prefLabel

Expression of dopamine 2 recep ...... unctioning pituitary adenomas.

@en

Expression of dopamine 2 recep ...... unctioning pituitary adenomas.

@nl

P1476

Expression of dopamine 2 recep ...... unctioning pituitary adenomas.

@en

P2093

Chengde Wang

http://www.w3.org/2001/XMLSchema#string

Jinsen Wu

http://www.w3.org/2001/XMLSchema#string

Qichuan Zhuge

http://www.w3.org/2001/XMLSchema#string

Weiming Zheng

http://www.w3.org/2001/XMLSchema#string

Xiaolong Jiang

http://www.w3.org/2001/XMLSchema#string

Yanjun Zeng

http://www.w3.org/2001/XMLSchema#string

Yong Chen

http://www.w3.org/2001/XMLSchema#string

Yunxiang Chen

http://www.w3.org/2001/XMLSchema#string

Zhebao Wu

http://www.w3.org/2001/XMLSchema#string

Zhipeng Su

http://www.w3.org/2001/XMLSchema#string

P2860

Dopamine resistance of prolactinomas.

Nerve growth factor suppresses the transforming phenotype of human prolactinomas

A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas.

Medical therapy for clinically non-functioning pituitary adenomas.

Coexpression of dopamine and somatostatin receptor subtypes in corticotroph adenomas.

Dopamine D2 receptor isoforms expressed in AtT20 cells differentially couple to G proteins to acutely inhibit high voltage-activated calcium channels.

Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide.

Expression of D2RmRNA isoforms and ERmRNA isoforms in prolactinomas: correlation with the response to bromocriptine and with tumor biological behavior.

Dopamine D2 receptor gene expression in human adenohypophysial adenomas.

Minor tumour shrinkage in nonfunctioning pituitary adenomas by long-term treatment with the dopamine agonist cabergoline.

P2888

s10072-011-0701-6

P304

275-279

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10072-011-0701-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21748460

http://www.w3.org/2001/XMLSchema#string

Expression of dopamine 2 receptor subtype mRNA in clinically nonfunctioning pituitary adenomas.

about

P2860

P2860

Expression of dopamine 2 receptor subtype mRNA in clinically nonfunctioning pituitary adenomas.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698